Symposium: What Does the Microbiome Tell Us about Prevention and Treatment of AD/ADRD?
Joia Kai Capocchi(University of California, Irvine), David A. Jett(National Institute of Neurological Disorders and Stroke), Claudia Figueroa‐Romero(National Institute of Neurological Disorders and Stroke), Yvonne M. Nolan(University College Cork), Stefanie Grabrucker(University College Cork), Gina Faraci(University of California, Irvine), Jason A. Rothman(University of California, Riverside), Katrine Whiteson(University of California, Irvine), David M. Holtzman(Hope Center for Neurological Disorders), Sage J. B. Dunham(University of California, Irvine), Dong-oh Seo(Hope Center for Neurological Disorders), Rima Kaddurah‐Daouk(Duke University)
Cited by 5
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
Alzheimer disease
|Nature Reviews Disease Primers|2021|2.4k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k